Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin During Chemotherapy for Ovarian Function Preservation in Premenopausal Breast Cancer
NCT07127315Completed
- Sponsor
- Helwan University
- Start
- Jun 2022
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Randomised, open-label trial of goserelin in ovarian dysfunction (2 arms), sponsored by Helwan University. Primary endpoint: Anti-mullerian hormone level. Started Jun 2022; status: completed.
02
Drugs
goserelin
03
Conditions
ovarian dysfunction
Beyond the preview
Go deeper on NCT07127315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07127315.